NL-OMON26801暂停不适用
INJECTABLE BULKING AGENT FOR MALE URINARY INCONTINENCE TREATMENT:A MULTI-CENTRE PILOT SAFETY AND EFFICACY STUDY
ot sponsored trialperformer ZGT and Jeroen Bosch Ziekenhuis0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subject remains dry at night.
- •Ability to voluntarily stop micturition.
排除标准
- •Post-prostatectomy radiotherapy or brachytherapy.
- •Subject radiated as treatment of Prostate Cancer, being this interstitial or external, neo-adjuvant, therapeutic or adjuvant.
研究者
相似试验
已完成
4 期
INJECTABLE BULKING AGENT FOR MALE URINARY INCONTINENCE TREATMENT: A MULTI-CENTRE EFFECTIVENESS AND SAFETY PILOT STUDYincontinenceurine loss10046447NL-OMON43352Ziekenhuisgroep Twente30
进行中（未招募）
不适用
Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) - CP(BTX)PSEUCTR2007-001602-24-DEDepartment of Urology and Pediatric Urology - Justus-Liebig-University Giessen
尚未招募
3 期
To study whether anaesthetizing the deep urine passage in men decreases pain during cystoscopy and stent removalCTRI/2021/03/031761CMC Fluid research funding
尚未招募
3 期
To study whether anaesthetizing the deep urine passage in men decreases pain during cystoscopyCTRI/2021/03/031715CMC Fluid research funding
进行中（未招募）
不适用
BOTOX for the treatment of urinary incontinence in patients with bladder problems as a result of Multiple Sclerosisrinary incontinence due to neurogenic detrusor overactivity (NDO) resulting from multiple sclerosis (MS)MedDRA version: 14.1Level: PTClassification code 10046543Term: Urinary incontinenceSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2012-000957-30-BEAllergan Ltd.184